Inflammation control by inflammasomes
Kate Schroder heads the Inflammasome Laboratory at the Institute for Molecular Bioscience, University of Queensland, as an ARC Future Fellow. Kate’s PhD studies defined novel macrophage activation mechanisms (awarded 2005). Her subsequent postdoctoral research identified surprising inter-species divergence in the inflammatory programs of human versus mouse macrophages. As an NHMRC CJ Martin Fellow, Kate then trained with the pioneer of inflammasome biology, Jürg Tschopp, in Switzerland. Her current research interests include the molecular mechanisms governing inflammasome activity and caspase activation, the cellular mediators of inflammasome-dependent inflammation, and inflammasome suppression by autophagy and small molecule inhibitors. Kate is Deputy Director of the IMB Centre for Inflammation and Disease Research, and a member of the Scientific Advisory Board for Inflazome, a start-up company that is developing inflammasome inhibitors as therapeutics for human diseases.
Date:
5 June 2017, 12:00 (Monday, 7th week, Trinity 2017)
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Bernard Sunley Lecture Theatre
Speaker:
Associate Professor Kate Schroder (Head, Inflammasome Lab, Institute for Molecular Bioscience The University of Queensland Brisbane, Australia)
Organising department:
Kennedy Institute of Rheumatology
Organiser:
Gintare Kolesnikovaite (Kennedy Institute of Rheumatology)
Organiser contact email address:
Gintare.Kolesnikovaite@kennedy.ox.ac.uk
Host:
Jelena Bezbradica Mirkovic (KTRR SENIOR RESEARCH FELLOW)
Part of:
Kennedy Institute Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Gintare Kolesnikovaite
